BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36063062)

  • 1. Follow Up Imaging in Hepatocellular Cancer Ultrasound Screening Exams With Poor Visualization Scores.
    Bley E; Mohan N; Jackson I; Chaisidhivej N; Jarrett S; Lo KB; Navarro V; Rossi S; Rodgers SK; Kalman RS
    J Ultrasound Med; 2022 Dec; 41(12):3113-3118. PubMed ID: 36063062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score.
    King MJ; Lee KM; Rosberger S; Huang HH; Meza GH; Lewis S; Taouli B
    Abdom Radiol (NY); 2023 Jan; 48(1):263-270. PubMed ID: 36243829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
    Park MK; Lee DH; Hur BY; Lee HC; Lee YB; Yu SJ; Kim YJ; Yoon JH; Lee JH
    Radiology; 2023 Jun; 307(5):e222106. PubMed ID: 37249427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) Visualization Score: a reliability analysis on inter-reader agreement.
    Tiyarattanachai T; Bird KN; Lo EC; Mariano AT; Ho AA; Ferguson CW; Chima RS; Desser TS; Morimoto LN; Kamaya A
    Abdom Radiol (NY); 2021 Nov; 46(11):5134-5141. PubMed ID: 34228197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.
    Fetzer DT; Browning T; Xi Y; Yokoo T; Singal AG
    AJR Am J Roentgenol; 2022 Jun; 218(6):1010-1020. PubMed ID: 34910539
    [No Abstract]   [Full Text] [Related]  

  • 6. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
    Tiyarattanachai T; Fetzer DT; Kamaya A
    AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
    [No Abstract]   [Full Text] [Related]  

  • 7. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year.
    Millet JD; Kamaya A; Choi HH; Dahiya N; Murphy PM; Naveed MZ; O'Boyle M; Parra LA; Perez MG; Pirmoazen AM; Rodgers SK; Wasnik AP; Maturen KE
    J Am Coll Radiol; 2019 Dec; 16(12):1656-1662. PubMed ID: 31173745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
    Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis.
    Kang JH; Kim NH; Kim DH; Choi Y; Choi JI
    Ultrasound Med Biol; 2023 Oct; 49(10):2205-2212. PubMed ID: 37517886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of advanced hepatic fibrosis and sonographic visualization score: a dual-center study using ACR US LI-RADS.
    Choi HH; Perez MG; Millet JD; Liang T; Wasnik AP; Maturen KE; Kamaya A
    Abdom Radiol (NY); 2019 Apr; 44(4):1415-1422. PubMed ID: 30539252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis.
    Schoenberger H; Chong N; Fetzer DT; Rich NE; Yokoo T; Khatri G; Olivares J; Parikh ND; Yopp AC; Marrero JA; Singal AG
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1561-1569.e4. PubMed ID: 34119640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    Sevco TJ; Masch WR; Maturen KE; Mendiratta-Lala M; Wasnik AP; Millet JD
    AJR Am J Roentgenol; 2021 Sep; 217(3):644-650. PubMed ID: 34259543
    [No Abstract]   [Full Text] [Related]  

  • 13. US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma.
    Morgan TA; Maturen KE; Dahiya N; Sun MRM; Kamaya A;
    Abdom Radiol (NY); 2018 Jan; 43(1):41-55. PubMed ID: 28936543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of US LI-RADS in the LI-RADS Algorithm.
    Rodgers SK; Fetzer DT; Gabriel H; Seow JH; Choi HH; Maturen KE; Wasnik AP; Morgan TA; Dahiya N; O'Boyle MK; Kono Y; Sirlin CB; Kamaya A
    Radiographics; 2019; 39(3):690-708. PubMed ID: 31059393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
    Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
    JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance.
    Choi HH; Kim S; Shum DJ; Huang CY; Shui A; Fox RK; Khalili M
    Radiol Imaging Cancer; 2024 Jan; 6(1):e230118. PubMed ID: 38214600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS): An Overview with Technical and Practical Applications.
    Choi HH; Rodgers SK; Fetzer DT; Wasnik AP; Millet JD; Morgan TA; Dawkins A; Gabriel H; Kamaya A
    Acad Radiol; 2021 Oct; 28(10):1464-1476. PubMed ID: 32718745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis.
    Quek J; Tan DJH; Chan KE; Lim WH; Ng CH; Ren YP; Koh TK; Teh R; Xiao J; Fu C; Syn N; Teng M; Muthiah M; Fowler KJ; Sirlin CB; Loomba R; Huang DQ
    Dig Dis; 2023; 41(5):757-766. PubMed ID: 37231918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
    Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.